Checkpoint inhibitor-associated pneumonitis in non-small cell lung cancer: a cohort study with transcriptomic analysis of inflammatory mechanisms.

Zhao W, Shen S, Zhao H

Open source

DOI
10.1186/s12890-025-04005-0
Published
2025 Dec 17
Container
BMC pulmonary medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12890-025-04005-0,
  title = {Checkpoint inhibitor-associated pneumonitis in non-small cell lung cancer: a cohort study with transcriptomic analysis of inflammatory mechanisms.},
  author = {Zhao W and Shen S and Zhao H},
  year = {2025},
  journal = {BMC pulmonary medicine},
  doi = {10.1186/s12890-025-04005-0},
  url = {https://doi.org/10.1186/s12890-025-04005-0}
}

RIS

TY  - JOUR
TI  - Checkpoint inhibitor-associated pneumonitis in non-small cell lung cancer: a cohort study with transcriptomic analysis of inflammatory mechanisms.
AU  - Zhao W
AU  - Shen S
AU  - Zhao H
PY  - 2025
JO  - BMC pulmonary medicine
DO  - 10.1186/s12890-025-04005-0
UR  - https://doi.org/10.1186/s12890-025-04005-0
ER  - 

APA

W, Z., S, S., & H, Z. (2025). Checkpoint inhibitor-associated pneumonitis in non-small cell lung cancer: a cohort study with transcriptomic analysis of inflammatory mechanisms.. BMC pulmonary medicine. https://doi.org/10.1186/s12890-025-04005-0

Source records